SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-22-003052
Filing Date
2022-04-29
Accepted
2022-04-29 16:45:36
Documents
2
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT 1 phio_i10ka1-123121.htm 10-K/A 215740
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER phio_ex3102.htm EX-31.2 3978
  Complete submission text file 0001683168-22-003052.txt   220850
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36304 | Film No.: 22876583
SIC: 2834 Pharmaceutical Preparations